Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
November-2020 Volume 20 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2020 Volume 20 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article

Significance of age‑associated quality of life in patients with stage IV breast cancer who underwent endocrine therapy in Japan

  • Authors:
    • Koji Takada
    • Shinichiro Kashiwagi
    • Yuka Asano
    • Wataru Goto
    • Tamami  Morisaki
    • Katsuyuki Takahashi
    • Masatsune Shibutani
    • Ryosuke Amano
    • Tsutomu  Takashima
    • Shuhei Tomita
    • Kosei Hirakawa
    • Masaichi Ohira
  • View Affiliations / Copyright

    Affiliations: Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka 545‑8585, Japan, Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka 545‑8585, Japan, Department of Gastrointestinal Surgery, Osaka City University Graduate School of Medicine, Osaka 545‑8585, Japan, Department of Hepato‑Biliary‑Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka 545‑8585, Japan
  • Article Number: 180
    |
    Published online on: August 31, 2020
       https://doi.org/10.3892/ol.2020.12041
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Currently, when determining treatment regimens, there is an emphasis on the quality of life (QOL), in addition to treatment efficacy. Especially in hormone receptor‑positive breast cancer with distant metastases, unless death is imminent, a common first‑line treatment is endocrine therapy, which has fewer side effects. In the present study, the differences in QOL were evaluated based on the age and prognostic indicators of 46 patients with hormone receptor‑positive breast cancer with distant metastases (stage IV), who received first‑line endocrine therapy at the Osaka City University Hospital (Osaka, Japan) between November 2007 and November 2016. QOL score before and after endocrine therapy was retrospectively analyzed, using the Quality of Life Questionnaire for Cancer Patients Treated with Anti‑Cancer Drugs‑Breast (QOL‑ACD‑B). There was no significant association between age and any of the clinicopathological features investigated. However, the QOL score of the elderly patient group was significantly higher compared with that of the younger group in the ‘Satisfaction with treatment and coping with disease’ subcategory (P=0.008). The QOL score of the younger age group in the same subcategory was significantly improved by the treatment (P=0.013). The patients that had an increased overall QOL score 3 months after treatment initiation had a significant extension of progression‑free survival (PFS) rate compared to the patients with decreased or no change in QOL (P=0.032). In conclusion, psychological stress was more prominent in younger patients with stage IV breast cancer treated with hormonal therapy compared with elderly patients. Importantly, improving QOL within the 3 months after treatment initiation could lead to longer PFS rate.
View Figures

Figure 1

Figure 2

View References

1 

Saracci R: The World Health Organisation needs to reconsider its definition of health. BMJ. 314:1409–1410. 1997. View Article : Google Scholar : PubMed/NCBI

2 

Maisey NR, Norman A, Watson M, Allen MJ, Hill ME and Cunningham D: Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer. 38:1351–1357. 2002. View Article : Google Scholar : PubMed/NCBI

3 

Kaasa S, Mastekaasa A and Lund E: Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients' subjective experience of disease and psychosocial well-being. Radiother Oncol. 15:235–242. 1989. View Article : Google Scholar : PubMed/NCBI

4 

Gotay CC, Kawamoto CT, Bottomley A and Efficace F: The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol. 26:1355–1363. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Dancey J, Zee B, Osoba D, Whitehead M, Lu F, Kaizer L, Latreille J and Pater JL: Quality of life scores: An independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res. 6:151–158. 1997. View Article : Google Scholar : PubMed/NCBI

6 

Hortobagyi GN: Treatment of breast cancer. N Engl J Med. 339:974–984. 1998. View Article : Google Scholar : PubMed/NCBI

7 

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M and Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics, : Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst. 97:1180–1184. 2005. View Article : Google Scholar : PubMed/NCBI

8 

Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247. 2009. View Article : Google Scholar : PubMed/NCBI

9 

Kurihara M, Shimizu H, Tsuboi K, Kobayashi K, Murakami M, Eguchi K and Shimozuma K: Development of quality of life questionnaire in Japan: Quality of life assessment of cancer patients receiving chemotherapy. Psychooncology. 8:355–363. 1999. View Article : Google Scholar : PubMed/NCBI

10 

Otsuka S, Watanabe N, Sasaki Y and Shimojima R: Postoperative courses of breast reconstruction using inferior adipofascial tissue repair. Breast Cancer. 22:570–577. 2015. View Article : Google Scholar : PubMed/NCBI

11 

Crivellari D, Aapro M, Leonard R, von Minckwitz G, Brain E, Goldhirsch A, Veronesi A and Muss H: Breast cancer in the elderly. J Clin Oncol. 25:1882–1890. 2007. View Article : Google Scholar : PubMed/NCBI

12 

Louwman WJ, Vulto JC, Verhoeven RH, Nieuwenhuijzen GA, Coebergh JW and Voogd AC: Clinical epidemiology of breast cancer in the elderly. Eur J Cancer. 43:2242–2252. 2007. View Article : Google Scholar : PubMed/NCBI

13 

Gennari R, Curigliano G, Rotmensz N, Robertson C, Colleoni M, Zurrida S, Nolè F, de Braud F, Orlando L, Leonardi MC, et al: Breast carcinoma in elderly women: Features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients. Cancer. 101:1302–1310. 2004. View Article : Google Scholar : PubMed/NCBI

14 

Wildiers H, Kunkler I, Biganzoli L, Fracheboud J, Vlastos G, Bernard-Marty C, Hurria A, Extermann M, Girre V, Brain E, et al: Management of breast cancer in elderly individuals: Recommendations of the International Society of Geriatric Oncology. Lancet Oncol. 8:1101–1115. 2007. View Article : Google Scholar : PubMed/NCBI

15 

Shimozuma K, Sonoo H, Ichihara K and Tanaka K: The prognostic value of quality-of-life scores: Preliminary results of an analysis of patients with breast cancer. Surg Today. 30:255–261. 2000. View Article : Google Scholar : PubMed/NCBI

16 

Schou I, Ekeberg O, Sandvik L, Hjermstad MJ and Ruland CM: Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population. Qual Life Res. 14:1813–1823. 2005. View Article : Google Scholar : PubMed/NCBI

17 

Watters JM, Yau JC, O'Rourke K, Tomiak E and Gertler SZ: Functional status is well maintained in older women during adjuvant chemotherapy for breast cancer. Ann Oncol. 14:1744–1750. 2003. View Article : Google Scholar : PubMed/NCBI

18 

Akin S, Can G, Durna Z and Aydiner A: The quality of life and self-efficacy of Turkish breast cancer patients undergoing chemotherapy. Eur J Oncol Nurs. 12:449–456. 2008. View Article : Google Scholar : PubMed/NCBI

19 

Hurwitz N: Predisposing factors in adverse reactions to drugs. Br Med J. 1:536–539. 1969. View Article : Google Scholar : PubMed/NCBI

20 

Cassidy J, Twelves C, Van Cutsem E, Hoff P, Bajetta E, Boyer M, Bugat R, Burger U, Garin A, Graeven U, et al: First-line oral capecitabine therapy in metastatic colorectal cancer: A favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol. 13:566–575. 2002. View Article : Google Scholar : PubMed/NCBI

21 

Levy M, Kewitz H, Altwein W, Hillebrand J and Eliakim M: Hospital admissions due to adverse drug reactions: A comparative study from Jerusalem and Berlin. Eur J Clin Pharmacol. 17:25–31. 1980. View Article : Google Scholar : PubMed/NCBI

22 

Hurria A, Hurria A, Zuckerman E, Panageas KS, Fornier M, D'Andrea G, Dang C, Moasser M, Robson M, Seidman A, et al: A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy. J Am Geriatr Soc. 54:1119–1124. 2006. View Article : Google Scholar : PubMed/NCBI

23 

Mols F, Vingerhoets AJ, Coebergh JW and van de Poll-Franse LV: Quality of life among long-term breast cancer survivors: A systematic review. Eur J Cancer. 41:2613–2619. 2005. View Article : Google Scholar : PubMed/NCBI

24 

Chee Chean D, Kuo Zang W, Lim M and Zulkefle N: Health Related Quality of Life (HRQoL) among breast cancer patients receiving chemotherapy in Hospital Melaka: Single Centre Experience. Asian Pac J Cancer Prev. 17:5121–5126. 2016.PubMed/NCBI

25 

Llombart-Cussac A, Pivot X, Biganzoli L, Cortes-Funes H, Pritchard KI, Pierga JY, Smith I, Thomssen C, Srock S, Sampayo M and Cortes J: A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial. Breast. 23:656–662. 2014. View Article : Google Scholar : PubMed/NCBI

26 

Dunphy FR, Spitzer G, Fornoff JE, Yau JC, Huan SD, Dicke KA, Buzdar AU and Hortobagyi GN: Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support. Cancer. 73:2157–2167. 1994. View Article : Google Scholar : PubMed/NCBI

27 

Tsuji W, Teramukai S, Ueno M, Toi M and Inamoto T: Prognostic factors for survival after first recurrence in breast cancer: A retrospective analysis of 252 recurrent cases at a single institution. Breast Cancer. 21:86–95. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Coates A, Gebski V, Signorini D, Murray P, McNeil D, Byrne M and Forbes JF: Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. J Clin Oncol. 10:1833–1838. 1992. View Article : Google Scholar : PubMed/NCBI

29 

Spiegel D, Bloom JR, Kraemer HC and Gottheil E: Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 2:888–891. 1989. View Article : Google Scholar : PubMed/NCBI

30 

Spiegel D, Sephton SE, Terr AI and Stites DP: Effects of psychosocial treatment in prolonging cancer survival may be mediated by neuroimmune pathways. Ann N Y Acad Sci. 840:674–683. 1998. View Article : Google Scholar : PubMed/NCBI

31 

Kuchler T, Bestmann B, Rappat S, Henne-Bruns D and Wood-Dauphinee S: Impact of psychotherapeutic support for patients with gastrointestinal cancer undergoing surgery: 10-year survival results of a randomized trial. J Clin Oncol. 25:2702–2708. 2007. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Takada K, Kashiwagi S, Asano Y, Goto W, Morisaki T, Takahashi K, Shibutani M, Amano R, Takashima T, Tomita S, Tomita S, et al: Significance of age‑associated quality of life in patients with stage IV breast cancer who underwent endocrine therapy in Japan. Oncol Lett 20: 180, 2020.
APA
Takada, K., Kashiwagi, S., Asano, Y., Goto, W., Morisaki, T., Takahashi, K. ... Ohira, M. (2020). Significance of age‑associated quality of life in patients with stage IV breast cancer who underwent endocrine therapy in Japan. Oncology Letters, 20, 180. https://doi.org/10.3892/ol.2020.12041
MLA
Takada, K., Kashiwagi, S., Asano, Y., Goto, W., Morisaki, T., Takahashi, K., Shibutani, M., Amano, R., Takashima, T., Tomita, S., Hirakawa, K., Ohira, M."Significance of age‑associated quality of life in patients with stage IV breast cancer who underwent endocrine therapy in Japan". Oncology Letters 20.5 (2020): 180.
Chicago
Takada, K., Kashiwagi, S., Asano, Y., Goto, W., Morisaki, T., Takahashi, K., Shibutani, M., Amano, R., Takashima, T., Tomita, S., Hirakawa, K., Ohira, M."Significance of age‑associated quality of life in patients with stage IV breast cancer who underwent endocrine therapy in Japan". Oncology Letters 20, no. 5 (2020): 180. https://doi.org/10.3892/ol.2020.12041
Copy and paste a formatted citation
x
Spandidos Publications style
Takada K, Kashiwagi S, Asano Y, Goto W, Morisaki T, Takahashi K, Shibutani M, Amano R, Takashima T, Tomita S, Tomita S, et al: Significance of age‑associated quality of life in patients with stage IV breast cancer who underwent endocrine therapy in Japan. Oncol Lett 20: 180, 2020.
APA
Takada, K., Kashiwagi, S., Asano, Y., Goto, W., Morisaki, T., Takahashi, K. ... Ohira, M. (2020). Significance of age‑associated quality of life in patients with stage IV breast cancer who underwent endocrine therapy in Japan. Oncology Letters, 20, 180. https://doi.org/10.3892/ol.2020.12041
MLA
Takada, K., Kashiwagi, S., Asano, Y., Goto, W., Morisaki, T., Takahashi, K., Shibutani, M., Amano, R., Takashima, T., Tomita, S., Hirakawa, K., Ohira, M."Significance of age‑associated quality of life in patients with stage IV breast cancer who underwent endocrine therapy in Japan". Oncology Letters 20.5 (2020): 180.
Chicago
Takada, K., Kashiwagi, S., Asano, Y., Goto, W., Morisaki, T., Takahashi, K., Shibutani, M., Amano, R., Takashima, T., Tomita, S., Hirakawa, K., Ohira, M."Significance of age‑associated quality of life in patients with stage IV breast cancer who underwent endocrine therapy in Japan". Oncology Letters 20, no. 5 (2020): 180. https://doi.org/10.3892/ol.2020.12041
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team